GNL Gut and Liver
  1. Huiyul Park, Mimi Kim, Hye‐Lin Kim, Seon Cho, Eileen L. Yoon, Dae Won Jun. Diagnostic performances of Fibrosis‐4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction‐associated steatotic liver disease in Asian primary care clinics. Hepatology Research 2024;54:1027
    https://doi.org/10.1111/hepr.14054
  2. Nahum Méndez-Sánchez, Willem Pieter Brouwer, Frank Lammert, Yusuf Yilmaz. Metabolic dysfunction associated fatty liver disease in healthy weight individuals. Hepatol Int 2024;18:884
    https://doi.org/10.1007/s12072-024-10662-w
  3. Michel A. Struwe, Axel J. Scheidig, Bernd Clement. The mitochondrial amidoxime reducing component—from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target. Journal of Biological Chemistry 2023;299:105306
    https://doi.org/10.1016/j.jbc.2023.105306
  4. Consolato M. Sergi. NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review. IJMS 2024;25:8462
    https://doi.org/10.3390/ijms25158462
  5. O.E. Abaturov, A.O. Nikulina. Genetic predisposition to metabolic dysfunction-associated fatty liver disease. CH 2024;19:162
    https://doi.org/10.22141/2224-0551.19.3.2024.1696
  6. Matheus Souza, Lubna Al-Sharif, Ivanna Diaz, Alessandro Mantovani, Cristiane Alves Villela-Nogueira. Global Epidemiology and Implications of PNPLA3 I148M Variant in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology 2025;15:102495
    https://doi.org/10.1016/j.jceh.2024.102495
  7. Yu Peng, Hangdong Shen, Chenyang Li, Xiaoyue Zhu, Yiqing Gao, Hongliang Yi, Huajun Xu, Jian Guan, Xinyi Li, Shankai Yin. Genetic variations of low-density lipoprotein cholesterol on metabolic disorders in obstructive sleep apnea. Nutr Metab (Lond) 2024;21
    https://doi.org/10.1186/s12986-024-00805-z
  8. Yuya Seko, Huapeng Lin, Vincent Wai‐Sun Wong, Takeshi Okanoue. Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease. Liver International 2024
    https://doi.org/10.1111/liv.16164
  9. Ziyan Pan, Maryam Al Khatry, Ming-Lung Yu, Ashok Choudhury, Giada Sebastiani, Saleh A. Alqahtani, Mohammed Eslam. MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight. Therapeutic Advances in Endocrinology 2024;15
    https://doi.org/10.1177/20420188241252543
  10. Gina Ryu, Eileen Laurel Yoon, Wankyu Kim, Dae Won Jun. Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis. Diagnostics 2025;15:342
    https://doi.org/10.3390/diagnostics15030342
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd